Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HOLSTED DYREKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   8.6% 4.8% 7.4% 5.6% 5.5% 4.3% 20.0% 19.7%   Credit score (0-100)   30 46 32 39 40 47 6 6   Credit rating   BB BBB BB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,772 1,869 2,391 2,671 2,892 2,743 0.0 0.0   EBITDA   63.1 267 240 157 135 540 0.0 0.0   EBIT   -106 142 88.3 33.7 16.3 449 0.0 0.0   Pre-tax profit (PTP)   -106.3 141.4 84.6 33.0 11.8 448.8 0.0 0.0   Net earnings   -83.8 110.0 71.2 25.3 8.8 350.0 0.0 0.0   Pre-tax profit without non-rec. items   -106 141 84.6 33.0 11.8 449 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   373 395 304 229 144 168 0.0 0.0   Shareholders equity total   33.0 143 214 239 248 203 123 123   Interest-bearing liabilities   489 410 0.0 72.3 190 84.3 0.0 0.0   Balance sheet total (assets)   1,178 1,120 1,516 1,049 1,077 1,015 123 123   Net Debt   56.0 -31.1 -362 -424 -303 -443 -123 -123     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,772 1,869 2,391 2,671 2,892 2,743 0.0 0.0   Gross profit growth   -1.4% 5.5% 27.9% 11.7% 8.3% -5.1% -100.0% 0.0%   Employees   5 4 5 5 6 5 0 0   Employee growth %   0.0% -20.0% 25.0% 0.0% 20.0% -16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,178 1,120 1,516 1,049 1,077 1,015 123 123   Balance sheet change%   -10.0% -4.9% 35.5% -30.8% 2.7% -5.8% -87.9% 0.0%   Added value   63.1 267.4 240.4 157.4 140.0 539.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -287 -103 -244 -198 -204 -67 -168 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -6.0% 7.6% 3.7% 1.3% 0.6% 16.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -8.5% 12.4% 6.7% 2.8% 1.5% 42.9% 0.0% 0.0%   ROI %   -17.4% 25.5% 18.3% 10.2% 4.1% 120.2% 0.0% 0.0%   ROE %   -112.0% 125.0% 39.9% 11.1% 3.6% 155.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   2.8% 12.8% 14.1% 22.8% 23.0% 20.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   88.9% -11.6% -150.8% -269.4% -224.0% -82.1% 0.0% 0.0%   Gearing %   1,483.7% 287.1% 0.0% 30.2% 76.4% 41.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.1% 0.2% 1.8% 8.3% 3.4% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.5 0.8 0.7 0.7 0.7 0.0 0.0   Current Ratio   0.7 0.8 1.0 1.0 1.1 1.0 0.0 0.0   Cash and cash equivalent   433.1 441.3 362.5 496.4 492.4 527.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -351.0 -221.9 56.7 25.1 106.6 31.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   13 67 48 31 23 108 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   13 67 48 31 23 108 0 0   EBIT / employee   -21 36 18 7 3 90 0 0   Net earnings / employee   -17 27 14 5 1 70 0 0